Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 6.
Article
Magalhaes, J;
Gegg, ME;
Migdalska-Richards, A;
Doherty, MK;
Whitfield, PD;
Schapira, AH;
(2016)
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.
Human Molecular Genetics
10.1093/hmg/ddw185.
(In press).
|
|
Magalhaes, J;
Gegg, ME;
Migdalska-Richards, A;
Schapira, AH;
(2018)
Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.
Scientific Reports
, 8
(1)
, Article 1385. 10.1038/s41598-018-19479-8.
|
 |
|
Migdalska-Richards, A;
Daly, L;
Bezard, E;
Schapira, AHV;
(2016)
Ambroxol effects in glucocerebrosidase and -synuclein transgenic mice.
Annals of Neurology
, 80
(5)
pp. 766-775.
10.1002/ana.24790.
|
|
|
Migdalska-Richards, A;
Ko, WKD;
Li, Q;
Bezard, E;
Schapira, AHV;
(2017)
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate.
Synapse
10.1002/syn.21967.
|
|
|
Migdalska-Richards, A;
Schapira, AHV;
(2016)
The relationship between glucocerebrosidase mutations and Parkinson disease.
JOURNAL OF NEUROCHEMISTRY
, 139
(S1)
pp. 77-90.
10.1111/jnc.13385.
|
|
Migdalska-Richards, A;
Wegrzynowicz, M;
Rusconi, R;
Deangeli, G;
Di Monte, DA;
Spillantini, MG;
Schapira, AHV;
(2017)
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.
Brain
, 140
(10)
pp. 2706-2721.
10.1093/brain/awx221.
|
